IL58478A0 - Pharmaceutical composition containing 3,4-dihydro-3-oxo-2-quinoxalines - Google Patents

Pharmaceutical composition containing 3,4-dihydro-3-oxo-2-quinoxalines

Info

Publication number
IL58478A0
IL58478A0 IL58478A IL5847879A IL58478A0 IL 58478 A0 IL58478 A0 IL 58478A0 IL 58478 A IL58478 A IL 58478A IL 5847879 A IL5847879 A IL 5847879A IL 58478 A0 IL58478 A0 IL 58478A0
Authority
IL
Israel
Prior art keywords
quinoxalines
dihydro
oxo
pharmaceutical composition
composition containing
Prior art date
Application number
IL58478A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL58478A0 publication Critical patent/IL58478A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/07Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
    • C07C205/11Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
    • C07C205/12Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings the six-membered aromatic ring or a condensed ring system containing that ring being substituted by halogen atoms
IL58478A 1978-10-20 1979-10-17 Pharmaceutical composition containing 3,4-dihydro-3-oxo-2-quinoxalines IL58478A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95315778A 1978-10-20 1978-10-20
US6044579A 1979-07-25 1979-07-25

Publications (1)

Publication Number Publication Date
IL58478A0 true IL58478A0 (en) 1980-01-31

Family

ID=26739938

Family Applications (1)

Application Number Title Priority Date Filing Date
IL58478A IL58478A0 (en) 1978-10-20 1979-10-17 Pharmaceutical composition containing 3,4-dihydro-3-oxo-2-quinoxalines

Country Status (19)

Country Link
US (1) US4264600A (xx)
EP (1) EP0010426A1 (xx)
JP (1) JPS5569514A (xx)
AU (1) AU5197779A (xx)
BE (1) BE879472A (xx)
CA (1) CA1145337A (xx)
DD (1) DD146705A5 (xx)
DK (1) DK444479A (xx)
ES (2) ES485221A1 (xx)
FI (1) FI793261A (xx)
FR (2) FR2439188A1 (xx)
GB (1) GB2034302A (xx)
GR (1) GR72941B (xx)
IL (1) IL58478A0 (xx)
IT (1) IT1193847B (xx)
LU (1) LU81798A1 (xx)
PH (1) PH15791A (xx)
PT (1) PT70340A (xx)
RO (1) RO78225A (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4252954A (en) * 1979-10-25 1981-02-24 Eli Lilly And Company Salts of dihalo-3,4-dihydro-3-oxo-2-quinoxaline carboxylic acids and hindered amines
US4355030A (en) * 1980-11-14 1982-10-19 Eli Lilly And Company Antiviral combinations
JPH0678319B2 (ja) * 1986-03-11 1994-10-05 東ソー株式会社 キノキサリノン誘導体
US5037983A (en) * 1988-05-16 1991-08-06 E. R. Squibb & Sons, Inc. 6,7-dihydroxyquinoxalines as intermediates to beta-lactam antibiotics
US4904775A (en) * 1988-05-16 1990-02-27 E. R. Squibb & Sons, Inc. Heteroaroylhydrazide derivatives of monocyclic beta-lactam antibiotics
CA2024282A1 (en) * 1989-09-21 1991-03-22 Peter H. Ermann Heterocyclic hydrazide derivatives of monocyclic beta-lactam antibiotics
US5169955A (en) * 1990-03-01 1992-12-08 Nippon Kayaku Kabushiki Kaisha Process for producing 2-hydroxyquinoxaline derivatives
ZA918014B (en) * 1990-11-05 1992-07-29 Squibb & Sons Inc Heteroaroyl derivatives of monocyclic beta-lactam antibiotics
AU9049391A (en) * 1990-12-20 1992-07-22 Warner-Lambert Company 2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity
US5250691A (en) * 1991-09-09 1993-10-05 E. R. Squibb & Sons, Inc. Heteroaryl derivatives of monocyclic beta-lactam antibiotics
TW274550B (xx) * 1992-09-26 1996-04-21 Hoechst Ag
HUP0002853A3 (en) * 1997-09-01 2001-12-28 Kyorin Seiyaku Kk 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, and pharmaceutical compositions containing them
CA2845241A1 (en) * 2010-08-14 2012-02-23 Versitech Limited Anti-viral carbamimidothioic acid esters
KR102278760B1 (ko) * 2012-12-20 2021-07-20 큉-빈 루 방사선과 조합하여 사용하는 할로겐- 및 디아미노-를 포함하는 방사선 증감제 화합물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1038505A (en) * 1963-06-04 1966-08-10 Daiichi Seiyaku Co Antileprosy ointment
CH513884A (de) * 1967-10-23 1971-10-15 Donau Pharmazie Gmbh Verfahren zur Herstellung von Tetrahydro-Chinoxalin-2-onen
GB1215815A (en) 1967-12-20 1970-12-16 Research Corp Production of quinoxaline-di-n-oxides and benzimidazole mono- and di-n-oxides
GB1408675A (en) 1973-03-16 1975-10-01 Allen & Hanburys Ltd Amides derived from quinoxaline
US3654275A (en) * 1969-10-15 1972-04-04 Pfizer & Co C Quinoxalinecarboxamide antiinflammatory agents
GB1308370A (en) 1969-12-09 1973-02-21 Research Corp 1-hydroxy-3-oxo-benzimidazoles quinoxaline-di-n-oxides and benzimidazole-mono-and di-n-oxides
US3962440A (en) * 1973-12-26 1976-06-08 Eli Lilly And Company Quinoxaline compounds as hypnotic agents

Also Published As

Publication number Publication date
PT70340A (en) 1979-10-01
CA1145337A (en) 1983-04-26
PH15791A (en) 1983-03-25
IT7926662A0 (it) 1979-10-19
ES485221A1 (es) 1980-07-01
FR2448899A1 (fr) 1980-09-12
ES485222A1 (es) 1980-09-01
GB2034302A (en) 1980-06-04
DD146705A5 (de) 1981-02-25
AU5197779A (en) 1980-05-01
LU81798A1 (fr) 1980-04-21
DK444479A (da) 1980-04-21
FR2439188A1 (fr) 1980-05-16
US4264600A (en) 1981-04-28
IT1193847B (it) 1988-08-24
RO78225A (ro) 1982-02-01
BE879472A (fr) 1980-04-18
GR72941B (xx) 1984-01-16
JPS5569514A (en) 1980-05-26
EP0010426A1 (en) 1980-04-30
FI793261A (fi) 1980-04-21

Similar Documents

Publication Publication Date Title
GB2039738B (en) Inflammation - preventing pharmaceutical composition
SG3185G (en) Compositions containing 1,3-dimethyl-5-aminoadamantane
JPS54132223A (en) Novel pharmaceutical composition
IL58123A0 (en) 4,5-diaryl-2-nitroimidazoles their preparation and pharmaceutical compositions containing them
IL57020A (en) Carbazolyl-(4)-oxypropanolamine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
NZ190299A (en) 1,2,4-trizole -3,5- diamines and pharmaceutical compositions
NZ190745A (en) Mercapto-substituted -2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutical compositions
IL58478A0 (en) Pharmaceutical composition containing 3,4-dihydro-3-oxo-2-quinoxalines
NZ189939A (en) N-oxacyclic-alkylpiperidyl-diaza compounds pharmaceutical compositions
NZ189684A (en) Substituted 2-phenylimino-imidazolidines pharmaceutical compositions
DE2962423D1 (en) Solid stable pharmaceutical composition on the basis of a 1,3-diester of 17-alpha-ethynyl-7-alpha-methyl-1,3,5(10)-estratriene-1,3,17-beta-triol
IL56577A (en) Pharmaceutical compositions comprising certain 1-substituted-2-pyrrolidinones
IL58415A (en) Substituted octahydro-7-phenylquinolizines,their manufacture and pharmaceutical compositions containing them
IL57213A0 (en) Substituted 8-hydroxy-1-phenyl-2,3,4,5-tetra-hydro-1h-3-benzazepines,process for the preparation thereof,and pharmaceutical compositions containing them
NZ189881A (en) 4,5-diaryl-2-(substituted-thio)-pyrroles and pharmaceutical compositions
GB2048671B (en) Pharmaceutical composition containing dihydroegotoxine
GB2034587B (en) Pharmaceutical compositions
JPS54154516A (en) Pharmaceutical composition
GB2039218B (en) Pharmaceutical compositions
GB2031727B (en) Pharmaceutical compositions
JPS5527168A (en) Drug composition
GB2026861B (en) Pharmaceutical compositions containing 5-methyl-7-diethylamino-s-triazolo (1,5- )-pyrimidine
ZA794484B (en) Pharmaceutical compositions
IL56613A (en) Chloromethyl 17 alpha-acetoxy-9alpha-fluoro-11beta-hydroxy-16beta-methyl-3-oxoandrosta-1,4-diene-17beta-carboxylate,its preparation and pharmaceutical compositions containing same
IL57196A (en) 1,6-dimesyl-3,4-dimethyl-d-mannitol,its preparation and pharmaceutical compositions containing it